The table below shows the serious adverse reactions that happened during this
study.
Serious adverse reactions during this study
Participants Participants Participants
with AML with DLBCL with MM
(out of 27 (out of 22 (out of 18
Serious adverse reaction participants) participants) participants)
Fever caused by a decrease in the
number of neutrophils, which are a
7.4% (2) 9.1% (2) 11.1% (2)
type of white blood cell that fight
infection and disease
Decrease in the number of platelets,
which are a type of blood cell that 0.0% (0) 0.0% (0) 11.1% (2)
form clots to stop bleeding
Blistering and peeling of the skin 3.7% (1) 0.0% (0) 0.0% (0)
Decrease in the number of red and
white blood cells and platelets, which 3.7% (1) 0.0% (0) 0.0% (0)
can cause several medical problems
Disease of the liver, gallbladder, or
3.7% (1) 0.0% (0) 0.0% (0)
bile ducts
Increase in the amount of proteins
in the liver, a sign of possible liver 3.7% (1) 0.0% (0) 0.0% (0)
damage
Lung infection 3.7% (1) 0.0% (0) 0.0% (0)
Decrease in the number of red blood
0.0% (0) 4.5% (1) 0.0% (0)
cells in the body
Decrease in the number of
neutrophils, which are a type of white
0.0% (0) 0.0% (0) 5.6% (1)
blood cell that fight infection and
disease
Swelling in the prostate 0.0% (0) 0.0% (0) 5.6% (1)
11 | Clinical Study Results